Akzo Nobel N.V. Fields Drug Unit Bids Amid IPO Plans

AMSTERDAM/LONDON, Jan 4 (Reuters) - Akzo Nobel NV (AKZO.AS: Quote, Profile , Research) is in talks to sell its Organon drugs unit instead of listing it as planned, a person familiar with the situation said on Thursday, reviving speculation the Dutch chemicals group could bid for Britain's ICI (ICI.L: Quote, Profile , Research).

>>> Discuss This Story

Back to news